CCL5 and chondrosarcoma: Pretreatment of chondrosarcoma cells with PI3K inhibitor Ly294002 antagonized increase of VEGF production and angiogenesis by CCL5, as confirmed by siRNA against p85 reducing enhancement of VEGF expression and angiogenesis via CCL5 stimulation.